BioNote, Inc. (KRX:377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,385.00
+10.00 (0.23%)
Last updated: Jun 24, 2026, 2:15 PM KST
Market Cap442.71B -13.5%
Revenue (ttm)122.44B +15.6%
Net Income-50.23B
EPS-497.08
Shares Out 101.19M
PE Ration/a
Forward PEn/a
Dividend200.00 (4.36%)
Ex-Dividend DateMar 30, 2026
Volume91,126
Open4,300.00
Previous Close4,375.00
Day's Range4,290.00 - 4,580.00
52-Week Range4,320.00 - 6,320.00
Beta0.63
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements